000			01746 a2200469 4500
005			20250513121249.0
264		0	_c19970714
008			199707s 0 0 eng d
022			_a0161-5505
040			_aNLM _beng _cNLM
100	1		_aBehr, T M
245	0	0	_aPhase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. _h[electronic resource]
260			_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cJun 1997
300			_a858-70 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAged
650	0	4	_aAntibodies, Anti-Idiotypic _ximmunology
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aBone Marrow _xradiation effects
650	0	4	_aCarcinoembryonic Antigen _ximmunology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIodine Radioisotopes _xadverse effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xdiagnostic imaging
650	0	4	_aRadioimmunotherapy _xadverse effects
650	0	4	_aRadiotherapy Dosage
650	0	4	_aRisk Factors
650	0	4	_aTomography, Emission-Computed, Single-Photon
700	1		_aSharkey, R M
700	1		_aJuweid, M E
700	1		_aDunn, R M
700	1		_aVagg, R C
700	1		_aYing, Z
700	1		_aZhang, C H
700	1		_aSwayne, L C
700	1		_aVardi, Y
700	1		_aSiegel, J A
700	1		_aGoldenberg, D M
773	0		_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 38 _gno. 6 _gp. 858-70
999			_c9170069 _d9170069